Position in GEHC
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$362,854,284
-$19,322,990 QoQ
Shares Held
5,097,700
+9.4% QoQ
Ownership
1.12%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 62%
Shared 0%
None 38%
Common Shares in GEHC Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Boston Partners holds $845,303,270 across 12 Medical Devices names. GEHC ranks #1 (42.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GEHC |
GE HealthCare Technologies Inc.
This page
|
5,097,700 | $362,854,284 | |
| 2 | STE |
STERIS plc
|
862,253 | $190,670,005 | |
| 3 | MDT |
Medtronic plc
|
2,027,905 | $175,717,968 | |
| 4 | ZBH |
Zimmer Biomet Holdings, Inc.
|
569,009 | $51,449,793 | |
| 5 | HAE |
Haemonetics Corp
|
556,679 | $31,374,427 | |
| 6 | CTKB |
Cytek Biosciences, Inc.
|
5,802,773 | $25,358,118 | |
| 7 | BIO |
Bio-Rad Laboratories, Inc.
|
8,193 | $2,283,798 | |
| 8 | SNN |
Smith & Nephew PLC
|
59,303 | $1,884,649 |
All Filings in GEHC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $362,854,284 | 5,097,700 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $382,177,274 | 4,659,562 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $287,553,092 | 3,828,936 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||